Solid-phase synthesis of (3-proline,8-isoleucine)-,(1-sarcosine,3-proline,8-isoleucine)-, and (4-phenylalanine,8-isoleucine)angiotensin II as the antagonists of the parent hormone.
D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000138:chemical synthesis* / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000187:drug effects; D002855:Chromatography, Thin Layer; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D010455:Peptides / Q000138:chemical synthesis / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D011487:Protein Conformation; D011817:Rabbits; D011956:Receptors, Cell Surface / Q000187:drug effects; D013329:Structure-Activity Relationship
D010455:Peptides; D011956:Receptors, Cell Surface; D000804:Angiotensin II